"You decide and we provide."
Cart 0

BRIEF-Genentech says U.S. FDA approves Lucentis (ranibizumab injection) for diabetic retinopathy




reutersCOMPANYNEWS companyNews

* FDA approves Genentech’s Lucentis (ranibizumab injection) for diabetic retinopathy, the leading cause of blindness among working age adults in the United States




Older Post Newer Post


Leave a comment

Please note, comments must be approved before they are published